|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 40714 |
FusionGeneSummary for UGP2_CECR2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: UGP2_CECR2 | Fusion gene ID: 40714 | Hgene | Tgene | Gene symbol | UGP2 | CECR2 | Gene ID | 7360 | 27443 |
| Gene name | UDP-glucose pyrophosphorylase 2 | CECR2, histone acetyl-lysine reader | |
| Synonyms | UDPG|UDPGP|UDPGP2|UGP1|UGPP1|UGPP2|pHC379 | - | |
| Cytomap | 2p15 | 22q11.1-q11.21 | |
| Type of gene | protein-coding | protein-coding | |
| Description | UTP--glucose-1-phosphate uridylyltransferaseUDP-glucose diphosphorylaseUDP-glucose pyrophosphorylase 1UGPase 2UTP--glucose-1-phosphate uridylyltransferase 2UTP-glucose-1-phosphate uridyltransferaseUridyl diphosphate glucose pyrophosphorylase-1testi | cat eye syndrome critical region protein 2cat eye syndrome chromosome region, candidate 2 | |
| Modification date | 20180523 | 20180519 | |
| UniProtAcc | Q16851 | Q9BXF3 | |
| Ensembl transtripts involved in fusion gene | ENST00000394417, ENST00000467648, ENST00000487469, ENST00000337130, ENST00000445915, | ENST00000342247, ENST00000400585, ENST00000497534, ENST00000400573, ENST00000262608, | |
| Fusion gene scores | * DoF score | 5 X 4 X 3=60 | 3 X 3 X 3=27 |
| # samples | 6 | 4 | |
| ** MAII score | log2(6/60*10)=0 | log2(4/27*10)=0.567040592723894 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: UGP2 [Title/Abstract] AND CECR2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | CECR2 | GO:0043044 | ATP-dependent chromatin remodeling | 15640247 |
| Tgene | CECR2 | GO:0097194 | execution phase of apoptosis | 12762840 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BI026848 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - | ||
| ChiTaRS3.1 | BI026849 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000394417 | ENST00000342247 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000394417 | ENST00000400585 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000394417 | ENST00000497534 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000394417 | ENST00000400573 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000394417 | ENST00000262608 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000467648 | ENST00000342247 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000467648 | ENST00000400585 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000467648 | ENST00000497534 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000467648 | ENST00000400573 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000467648 | ENST00000262608 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000487469 | ENST00000342247 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000487469 | ENST00000400585 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000487469 | ENST00000497534 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000487469 | ENST00000400573 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000487469 | ENST00000262608 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000337130 | ENST00000342247 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000337130 | ENST00000400585 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000337130 | ENST00000497534 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000337130 | ENST00000400573 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000337130 | ENST00000262608 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000445915 | ENST00000342247 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000445915 | ENST00000400585 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000445915 | ENST00000497534 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000445915 | ENST00000400573 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
| intron-intron | ENST00000445915 | ENST00000262608 | UGP2 | chr2 | 64087013 | + | CECR2 | chr22 | 17896181 | - |
Top |
FusionProtFeatures for UGP2_CECR2 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| UGP2 | CECR2 |
| Plays a central role as a glucosyl donor in cellularmetabolic pathways. | Chromatin reader component of histone-modifyingcomplexes, such as the CERF (CECR2-containing-remodeling factor)complex and ISWI-type complex (PubMed:15640247, PubMed:26365797,PubMed:22464331). It thereby plays a role in various processesduring development: required during embryogenesis for neural tubeclosure and inner ear development. In adults, required forspermatogenesis, via the formation of ISWI-type chromatincomplexes (By similarity). In histone-modifying complexes, CECR2recognizes and binds acylated histones: binds histones that areacetylated and/or butyrylated (PubMed:26365797, PubMed:22464331).May also be involved through its interaction with LRPPRC in theintegration of cytoskeletal network with vesicular trafficking,nucleocytosolic shuttling, transcription, chromosome remodelingand cytokinesis (PubMed:11827465). {ECO:0000250|UniProtKB:E9Q2Z1,ECO:0000269|PubMed:11827465, ECO:0000269|PubMed:15640247,ECO:0000269|PubMed:22464331, ECO:0000269|PubMed:26365797}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for UGP2_CECR2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for UGP2_CECR2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for UGP2_CECR2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for UGP2_CECR2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | CECR2 | C0027794 | Neural Tube Defects | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|